- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01673152
The Effect of the Oligofructose Supplementation on Body Weight in Overweight and Obese Children
January 15, 2014 updated by: Hanna Szajewska, Medical University of Warsaw
The Effect of the Oligofructose Supplementation on Body Weight in Overweight and Obese Children: a Randomized, Double Blind, Placebo-controlled Trial
This study is designed to assess the effect of oligofructose administration for 12 weeks on Body Mass Index (BMI) of overweight and obese children.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The prevalence of childhood overweight and obesity is reaching epidemic proportions.
There have been no effective methods for preventing or treating obesity in childhood so far prompting interest in new interventions.
One potential option for obesity prevention is the use of the prebiotic oligofructose.
Data from research on rodents shows that a high-fat diet enriched with oligofructose causes a decrease in energy intake, less weight gain and a lower level of triglycerides .
A similar effect has been observed in healthy adults.
Available evidence suggests that the addition of oligofructose to the diets of overweight or obese adults may increase satiety and thus reduce energy intake.
Currently, there are no data on the effect of oligofructose in overweight and obese children.
Study Type
Interventional
Enrollment (Anticipated)
96
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Warsaw, Poland
- Samodzielny Publiczny Dzieciecy Szpital Kliniczny
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children aged 7 to 18 years
- BMI > 85 percentile
- Signed informed consent
Exclusion Criteria:
- Overweight / obesity secondary to genetic syndromes and/or endocrine diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Maltodextrin
|
Dosing: children aged 7 to 12 years: 4g/day, children aged 12 to18 years: 6g/day, Duration: 12 weeks
|
|
Experimental: Oligofructose
Orafti P95, Beneo-Orafti, Belgium,
|
Dosing: children aged 7 to 12 years: 8g/day, children aged 12 to18 years: 15g/day Duration: 12 weeks
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
BMI z-score difference
Time Frame: after 12 weeks of the intervention
|
after 12 weeks of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
BMI z-score difference
Time Frame: after 24 weeks of the intervention
|
after 24 weeks of the intervention
|
|
Percentage of weight reduction
Time Frame: after 12 weeks of the intervention
|
after 12 weeks of the intervention
|
|
Difference in total body fat measured by Dual-Energy X-ray Absorptiometry (DEXA)
Time Frame: after 12 weeks of the intervention
|
after 12 weeks of the intervention
|
|
Percentage of children with BMI-for-age > 85percentile
Time Frame: after 12 and 24 weeks of the intervention
|
after 12 and 24 weeks of the intervention
|
|
Mean BMI z-score
Time Frame: after 12 and 24 weeks of the intervention
|
after 12 and 24 weeks of the intervention
|
|
Self-reported energy intake (3-day diet record)
Time Frame: after 12 weeks of the intervention
|
after 12 weeks of the intervention
|
|
Percentage of the children with abnormal fasting glucose
Time Frame: after 12 weeks of the intervention
|
after 12 weeks of the intervention
|
|
Percentage of the children with dyslipidemias
Time Frame: after 12 weeks of the intervention
|
after 12 weeks of the intervention
|
|
Percentage of the children with hypertension
Time Frame: after 12 weeks of the intervention
|
after 12 weeks of the intervention
|
|
Adverse effects
Time Frame: during intervention
|
during intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
June 27, 2012
First Submitted That Met QC Criteria
August 23, 2012
First Posted (Estimate)
August 27, 2012
Study Record Updates
Last Update Posted (Estimate)
January 16, 2014
Last Update Submitted That Met QC Criteria
January 15, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RG 4/2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Maltodextrin
-
RDC Clinical Pty LtdCompletedJoint Pain | Muscle Pain | Chronic Inflammation | MobilityAustralia
-
University of ReadingABC Farmaceutici S.p.A.Recruiting
-
Muhammad N Aslam, MDCrohn's and Colitis FoundationNot yet recruitingUlcerative Colitis | Ileal PouchUnited States
-
Chung Shan Medical UniversityCompleted
-
Northwestern UniversityUniversity of Illinois at ChicagoActive, not recruitingParkinson Disease | Dietary Modification | Intestinal Bacteria Flora DisturbanceUnited States
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Central South UniversityHunan Children's HospitalNot yet recruitingObesity | Obese Children and Adolescents | Obese Adolescents | Akkermansia MuciniphilaChina
-
Princess Nourah Bint Abdulrahman UniversityNot yet recruitingInflammation | Obesity | Type 2 Diabetes | Gut Microbiome | Metabolic HealthSaudi Arabia
-
University of ViennaCRI Collagen Research Institute GmbHRecruiting
-
Federal University of Minas GeraisNestle Health ScienceRecruiting